These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2816612)

  • 1. [The role of urine pH in the occurrence of phosphaturia].
    Tozuka K; Hara Y; Moriguchi H; Kikuchi T; Tokue A
    Hinyokika Kiyo; 1989 Sep; 35(9):1475-8. PubMed ID: 2816612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical significance of phosphaturia].
    Tozuka K; Ishikawa S; Morita T; Kobayashi Y; Ishiyama S; Tokue A
    Nihon Hinyokika Gakkai Zasshi; 1989 May; 80(5):700-3. PubMed ID: 2754894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variability of the calcium ion activity with pH in stone-forming and non-stone-forming urine.
    Thode J; Holgersen RB; Gerstenberg T
    Scand J Clin Lab Invest Suppl; 1993; 214():121-6. PubMed ID: 8332846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of factors involved in calcium stone formation.
    Abraham PA; Smith CL
    Miner Electrolyte Metab; 1987; 13(3):201-8. PubMed ID: 3627051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary risk factors for recurrent calcium stone formation in Thai stone formers.
    Stitchantrakul W; Kochakarn W; Ruangraksa C; Domrongkitchaiporn S
    J Med Assoc Thai; 2007 Apr; 90(4):688-98. PubMed ID: 17487123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Calcium concentrations in the urine of recurrent stone-formers and their controls (author's transl)].
    Leskovar P; Hartung R; Siebert A; Wellnhofer E
    Urologe A; 1980 Jul; 19(4):207-13. PubMed ID: 7414765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spherical calcium bodies in stone-forming urine.
    Resnick MI; Boyce WH
    Invest Urol; 1978 May; 15(6):449-51. PubMed ID: 649292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical studies of the recurrence of urolithiasis (4). Crystal formation in urine and stone recurrence].
    Murayama T; Taguchi H
    Hinyokika Kiyo; 1988 Sep; 34(9):1543-7. PubMed ID: 3213790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin resistance and low urinary citrate excretion in calcium stone formers.
    Cupisti A; Meola M; D'Alessandro C; Bernabini G; Pasquali E; Carpi A; Barsotti G
    Biomed Pharmacother; 2007 Jan; 61(1):86-90. PubMed ID: 17184967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The most important metabolic risk factors in recurrent urinary stone formers.
    Parvin M; Shakhssalim N; Basiri A; Miladipour AH; Golestan B; Mohammadi Torbati P; Azadvari M; Eftekhari S
    Urol J; 2011; 8(2):99-106. PubMed ID: 21656467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and metabolic evaluation of Korean patients with urolithiasis.
    Park KJ; Jeon SS; Han DH; Lee SY
    Scand J Clin Lab Invest; 2011 Oct; 71(6):481-5. PubMed ID: 21714706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical studies on the recurrence of urolithiasis: (1). Influence of diet on urinary excretion of the stone forming constituents].
    Murayama T; Taguchi H
    Hinyokika Kiyo; 1987 Sep; 33(9):1321-30. PubMed ID: 3434487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of the diurnal variation of urinary pH and urinary calcium in urolithiasis: a study in outpatients.
    Murayama T; Sakai N; Yamada T; Takano T
    Int J Urol; 2001 Oct; 8(10):525-31; discussion 532. PubMed ID: 11737477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Urinary magnesium and its relationship to calcium in recurrent stone-formers and controls (author's transl)].
    Leskovar P; Hartung R; Siebert A; Wellnhofer E
    Urologe A; 1980 Jul; 19(4):214-9. PubMed ID: 7414766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical studies on the recurrence of urolithiasis (5). Diurnal variation in urinary pH and stone compositions].
    Murayama T; Taguchi H
    Hinyokika Kiyo; 1988 Oct; 34(10):1711-5. PubMed ID: 3245520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ca, P, and pH relationships during spontaneous phosphaturia.
    King JS; Rhyne AL
    Clin Chem; 1971 Oct; 17(10):1058-9. PubMed ID: 5095147
    [No Abstract]   [Full Text] [Related]  

  • 17. [A study on the cause of urolithiasis of the upper urinary tract--clinical study of risk factors in the formation of stones in the upper urinary tract].
    Nonomura M; Kawamura J; Ueda M; Okada Y; Takeuchi H; Yoshida O
    Hinyokika Kiyo; 1986 Mar; 32(3):311-25. PubMed ID: 3728237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simplified protocol for biochemical evaluation of recurrent renal calcium stone disease.
    Thode J; Finnerup B; Parvin C; Holmegaard SN; Skaarup P; Sørensen OH; Transbøl I
    Miner Electrolyte Metab; 1988; 14(5):288-96. PubMed ID: 2845241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary stone formers with hypocitraturia and 'normal' urinary pH are at high risk for recurrence.
    Strohmaier WL; Seilnacht J; Schubert G
    Urol Int; 2012; 88(3):294-7. PubMed ID: 22398801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postprandial hyperinsulinaemia, insulin resistance and inappropriately high phosphaturia are features of younger males with idiopathic calcium urolithiasis: attenuation by ascorbic acid supplementation of a test meal.
    Schwille PO; Schmiedl A; Herrmann U; Wipplinger J
    Urol Res; 1997; 25(1):49-58. PubMed ID: 9079746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.